Corynebacterium, Kingella abundance tied to HNSCC risk

January 12, 2018

(HealthDay)—The overall oral microbiome composition is not associated with the risk of head and neck squamous cell carcinoma (HNSCC), but greater abundance of genera Corynebacterium and Kingella is associated with decreased HNSCC risk, according to a study published online Jan. 11 in JAMA Oncology.

Richard B. Hayes, D.D.S., Ph.D., from the New York University School of Medicine in New York City, and colleagues conducted a nested case- study in two prospective cohort studies to examine the correlation between the oral microbiome and incident HNSCC. A total of 129 patient cases of HNSCC were identified among 122,004 participants during an average follow-up of 3.9 years. Two controls were selected for each patient case (254 controls); cases and controls were similar in terms of age, sex, and race/ethnicity.

The researchers observed no for overall microbiome composition with the risk of HNSCC. Decreased risk of HNSCC was seen in association with greater abundance of genera Corynebacterium (fold change, 0.58) and Kingella (fold change, 0.63), which was possibly related to carcinogen metabolism capacity. The correlations tended to be stronger for larynx cancer and for those with tobacco use history.

"This study demonstrates that greater oral abundance of commensal Corynebacterium and Kingella is associated with decreased risk of HNSCC, with potential implications for cancer prevention," the authors write.

Explore further: High CVD risk in patients with head, neck squamous cell cancer

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

High CVD risk in patients with head, neck squamous cell cancer

February 2, 2017
(HealthDay)—Twenty-three percent of patients with head and neck squamous cell carcinoma (HNSCC) have cardiovascular disease (CVD) at diagnosis, and 24 percent have uncontrolled blood pressure, according to research published ...

Periodontitis linked to HPV-positive head, neck tumors

June 20, 2012
(HealthDay) -- For patients with head and neck squamous cell carcinoma (HNSCC) there is an increased risk of human papillomavirus (HPV)-positive tumors among those with a history of periodontitis, according to a study published ...

How head and neck squamous cell carcinomas take over wound-healing processes

November 29, 2017
A*STAR researchers have identified the molecular means by which a common form of cancer hijacks wound-healing processes to help it spread. The team hope their findings could lead to more effective treatments.

MED15 involved in head and neck squamous cell carcinoma

April 2, 2015
(HealthDay)—The mediator subunit MED15 appears to be involved in head and neck squamous cell carcinoma (HNSCC), according to a study published in the April issue of The American Journal of Pathology.

Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma

March 20, 2015
A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated ...

Sensitizing tumor cells to radiotherapy

March 1, 2012
Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer worldwide. Tumor resistance to radio- and/or chemotherapy remains a significant clinical problem.

Recommended for you

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

Researcher fighting breast cancer with light therapy

October 17, 2018
When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.

New method uses just a drop of blood to monitor lung cancer treatment

October 17, 2018
Dr. Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. This discovery led to a set of anti-cancer medications called checkpoint inhibitors, one of the first of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.